nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—atherosclerosis	0.135	0.529	CbGaD
Etodolac—ALB—atherosclerosis	0.121	0.471	CbGaD
Etodolac—UGT1A3—Ezetimibe—atherosclerosis	0.0897	0.171	CbGbCtD
Etodolac—UGT1A3—Simvastatin—atherosclerosis	0.0834	0.159	CbGbCtD
Etodolac—UGT1A3—Lovastatin—atherosclerosis	0.0816	0.155	CbGbCtD
Etodolac—UGT2B7—Ezetimibe—atherosclerosis	0.0649	0.123	CbGbCtD
Etodolac—UGT2B7—Simvastatin—atherosclerosis	0.0603	0.115	CbGbCtD
Etodolac—UGT2B7—Lovastatin—atherosclerosis	0.059	0.112	CbGbCtD
Etodolac—SLC22A6—Pravastatin—atherosclerosis	0.0227	0.0432	CbGbCtD
Etodolac—ALB—Rosuvastatin—atherosclerosis	0.0213	0.0404	CbGbCtD
Etodolac—CYP2C9—Rosuvastatin—atherosclerosis	0.0115	0.0218	CbGbCtD
Etodolac—CYP2C9—Simvastatin—atherosclerosis	0.0107	0.0203	CbGbCtD
Etodolac—CYP2C9—Pravastatin—atherosclerosis	0.0104	0.0198	CbGbCtD
Etodolac—CYP2C9—Lovastatin—atherosclerosis	0.0104	0.0198	CbGbCtD
Etodolac—PTGS2—leg—atherosclerosis	0.000866	0.0957	CbGeAlD
Etodolac—UGT1A10—liver—atherosclerosis	0.000807	0.0892	CbGeAlD
Etodolac—PTGS2—hindlimb—atherosclerosis	0.000773	0.0854	CbGeAlD
Etodolac—PTGS2—appendage—atherosclerosis	0.000663	0.0733	CbGeAlD
Etodolac—UGT1A3—liver—atherosclerosis	0.000569	0.0628	CbGeAlD
Etodolac—PTGS1—artery—atherosclerosis	0.000496	0.0548	CbGeAlD
Etodolac—RXRA—liver—atherosclerosis	0.000481	0.0532	CbGeAlD
Etodolac—PTGS2—artery—atherosclerosis	0.000474	0.0524	CbGeAlD
Etodolac—PTGS1—endothelium—atherosclerosis	0.000419	0.0463	CbGeAlD
Etodolac—UGT1A9—liver—atherosclerosis	0.000405	0.0448	CbGeAlD
Etodolac—PTGS2—endothelium—atherosclerosis	0.0004	0.0442	CbGeAlD
Etodolac—PTGS1—blood vessel—atherosclerosis	0.000386	0.0427	CbGeAlD
Etodolac—PTGS2—blood vessel—atherosclerosis	0.000369	0.0408	CbGeAlD
Etodolac—UGT2B7—liver—atherosclerosis	0.000327	0.0361	CbGeAlD
Etodolac—Pharyngitis—Pravastatin—atherosclerosis	0.000275	0.00252	CcSEcCtD
Etodolac—Chills—Simvastatin—atherosclerosis	0.000275	0.00252	CcSEcCtD
Etodolac—Infection—Rosuvastatin—atherosclerosis	0.000273	0.0025	CcSEcCtD
Etodolac—Visual impairment—Niacin—atherosclerosis	0.000272	0.00248	CcSEcCtD
Etodolac—Alopecia—Simvastatin—atherosclerosis	0.000271	0.00248	CcSEcCtD
Etodolac—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000269	0.00246	CcSEcCtD
Etodolac—Vision blurred—Lovastatin—atherosclerosis	0.000269	0.00246	CcSEcCtD
Etodolac—Tremor—Lovastatin—atherosclerosis	0.000268	0.00245	CcSEcCtD
Etodolac—Visual impairment—Pravastatin—atherosclerosis	0.000267	0.00245	CcSEcCtD
Etodolac—Ill-defined disorder—Lovastatin—atherosclerosis	0.000265	0.00242	CcSEcCtD
Etodolac—Flatulence—Simvastatin—atherosclerosis	0.000263	0.00241	CcSEcCtD
Etodolac—Tinnitus—Niacin—atherosclerosis	0.000263	0.0024	CcSEcCtD
Etodolac—Erythema multiforme—Pravastatin—atherosclerosis	0.000262	0.0024	CcSEcCtD
Etodolac—Dysgeusia—Simvastatin—atherosclerosis	0.000262	0.00239	CcSEcCtD
Etodolac—Flushing—Niacin—atherosclerosis	0.000261	0.00239	CcSEcCtD
Etodolac—Angioedema—Lovastatin—atherosclerosis	0.000261	0.00239	CcSEcCtD
Etodolac—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00026	0.00238	CcSEcCtD
Etodolac—Anaemia—Ezetimibe—atherosclerosis	0.000259	0.00237	CcSEcCtD
Etodolac—Tinnitus—Pravastatin—atherosclerosis	0.000259	0.00237	CcSEcCtD
Etodolac—Malaise—Lovastatin—atherosclerosis	0.000258	0.00236	CcSEcCtD
Etodolac—Flushing—Pravastatin—atherosclerosis	0.000257	0.00235	CcSEcCtD
Etodolac—Vertigo—Lovastatin—atherosclerosis	0.000257	0.00235	CcSEcCtD
Etodolac—Angioedema—Ezetimibe—atherosclerosis	0.000256	0.00234	CcSEcCtD
Etodolac—Leukopenia—Lovastatin—atherosclerosis	0.000256	0.00234	CcSEcCtD
Etodolac—Chills—Niacin—atherosclerosis	0.000253	0.00231	CcSEcCtD
Etodolac—Malaise—Ezetimibe—atherosclerosis	0.000253	0.00231	CcSEcCtD
Etodolac—Vision blurred—Simvastatin—atherosclerosis	0.000252	0.0023	CcSEcCtD
Etodolac—Arrhythmia—Niacin—atherosclerosis	0.000252	0.0023	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000251	0.00229	CcSEcCtD
Etodolac—Tremor—Simvastatin—atherosclerosis	0.00025	0.00229	CcSEcCtD
Etodolac—Alopecia—Niacin—atherosclerosis	0.000249	0.00228	CcSEcCtD
Etodolac—Chills—Pravastatin—atherosclerosis	0.000249	0.00228	CcSEcCtD
Etodolac—Insomnia—Rosuvastatin—atherosclerosis	0.000249	0.00228	CcSEcCtD
Etodolac—Ill-defined disorder—Simvastatin—atherosclerosis	0.000248	0.00227	CcSEcCtD
Etodolac—Arrhythmia—Pravastatin—atherosclerosis	0.000248	0.00227	CcSEcCtD
Etodolac—Palpitations—Ezetimibe—atherosclerosis	0.000248	0.00226	CcSEcCtD
Etodolac—Paraesthesia—Rosuvastatin—atherosclerosis	0.000247	0.00226	CcSEcCtD
Etodolac—Anaemia—Simvastatin—atherosclerosis	0.000247	0.00226	CcSEcCtD
Etodolac—Alopecia—Pravastatin—atherosclerosis	0.000245	0.00224	CcSEcCtD
Etodolac—Angioedema—Simvastatin—atherosclerosis	0.000244	0.00223	CcSEcCtD
Etodolac—Arthralgia—Lovastatin—atherosclerosis	0.000243	0.00222	CcSEcCtD
Etodolac—Myalgia—Lovastatin—atherosclerosis	0.000243	0.00222	CcSEcCtD
Etodolac—Anxiety—Lovastatin—atherosclerosis	0.000242	0.00222	CcSEcCtD
Etodolac—Dyspepsia—Rosuvastatin—atherosclerosis	0.000242	0.00221	CcSEcCtD
Etodolac—Hypertension—Ezetimibe—atherosclerosis	0.000242	0.00221	CcSEcCtD
Etodolac—Flatulence—Niacin—atherosclerosis	0.000242	0.00221	CcSEcCtD
Etodolac—Malaise—Simvastatin—atherosclerosis	0.000241	0.0022	CcSEcCtD
Etodolac—Tension—Niacin—atherosclerosis	0.000241	0.0022	CcSEcCtD
Etodolac—Discomfort—Lovastatin—atherosclerosis	0.00024	0.0022	CcSEcCtD
Etodolac—Vertigo—Simvastatin—atherosclerosis	0.00024	0.00219	CcSEcCtD
Etodolac—Leukopenia—Simvastatin—atherosclerosis	0.000239	0.00219	CcSEcCtD
Etodolac—Myalgia—Ezetimibe—atherosclerosis	0.000238	0.00218	CcSEcCtD
Etodolac—Arthralgia—Ezetimibe—atherosclerosis	0.000238	0.00218	CcSEcCtD
Etodolac—Nervousness—Niacin—atherosclerosis	0.000238	0.00218	CcSEcCtD
Etodolac—Flatulence—Pravastatin—atherosclerosis	0.000238	0.00218	CcSEcCtD
Etodolac—Dry mouth—Lovastatin—atherosclerosis	0.000238	0.00217	CcSEcCtD
Etodolac—Tension—Pravastatin—atherosclerosis	0.000237	0.00217	CcSEcCtD
Etodolac—Dysgeusia—Pravastatin—atherosclerosis	0.000236	0.00216	CcSEcCtD
Etodolac—Discomfort—Ezetimibe—atherosclerosis	0.000236	0.00215	CcSEcCtD
Etodolac—Constipation—Rosuvastatin—atherosclerosis	0.000235	0.00215	CcSEcCtD
Etodolac—Pain—Rosuvastatin—atherosclerosis	0.000235	0.00215	CcSEcCtD
Etodolac—Confusional state—Lovastatin—atherosclerosis	0.000235	0.00215	CcSEcCtD
Etodolac—Nervousness—Pravastatin—atherosclerosis	0.000235	0.00215	CcSEcCtD
Etodolac—Dry mouth—Ezetimibe—atherosclerosis	0.000233	0.00213	CcSEcCtD
Etodolac—Anaphylactic shock—Lovastatin—atherosclerosis	0.000233	0.00213	CcSEcCtD
Etodolac—Infection—Lovastatin—atherosclerosis	0.000232	0.00212	CcSEcCtD
Etodolac—Vision blurred—Niacin—atherosclerosis	0.000231	0.00211	CcSEcCtD
Etodolac—Confusional state—Ezetimibe—atherosclerosis	0.00023	0.00211	CcSEcCtD
Etodolac—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000229	0.00209	CcSEcCtD
Etodolac—Thrombocytopenia—Lovastatin—atherosclerosis	0.000228	0.00209	CcSEcCtD
Etodolac—Vision blurred—Pravastatin—atherosclerosis	0.000228	0.00208	CcSEcCtD
Etodolac—Arthralgia—Simvastatin—atherosclerosis	0.000227	0.00208	CcSEcCtD
Etodolac—Myalgia—Simvastatin—atherosclerosis	0.000227	0.00208	CcSEcCtD
Etodolac—Infection—Ezetimibe—atherosclerosis	0.000227	0.00208	CcSEcCtD
Etodolac—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000227	0.00207	CcSEcCtD
Etodolac—Anxiety—Simvastatin—atherosclerosis	0.000227	0.00207	CcSEcCtD
Etodolac—Tremor—Pravastatin—atherosclerosis	0.000226	0.00207	CcSEcCtD
Etodolac—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000225	0.00206	CcSEcCtD
Etodolac—Discomfort—Simvastatin—atherosclerosis	0.000225	0.00206	CcSEcCtD
Etodolac—Angioedema—Niacin—atherosclerosis	0.000224	0.00205	CcSEcCtD
Etodolac—Ill-defined disorder—Pravastatin—atherosclerosis	0.000224	0.00205	CcSEcCtD
Etodolac—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000224	0.00205	CcSEcCtD
Etodolac—Anaemia—Pravastatin—atherosclerosis	0.000223	0.00204	CcSEcCtD
Etodolac—Anorexia—Lovastatin—atherosclerosis	0.000222	0.00203	CcSEcCtD
Etodolac—Angioedema—Pravastatin—atherosclerosis	0.000221	0.00202	CcSEcCtD
Etodolac—Vertigo—Niacin—atherosclerosis	0.00022	0.00202	CcSEcCtD
Etodolac—Syncope—Niacin—atherosclerosis	0.00022	0.00201	CcSEcCtD
Etodolac—Confusional state—Simvastatin—atherosclerosis	0.00022	0.00201	CcSEcCtD
Etodolac—Leukopenia—Niacin—atherosclerosis	0.00022	0.00201	CcSEcCtD
Etodolac—Urticaria—Rosuvastatin—atherosclerosis	0.000218	0.002	CcSEcCtD
Etodolac—Anaphylactic shock—Simvastatin—atherosclerosis	0.000218	0.00199	CcSEcCtD
Etodolac—Oedema—Simvastatin—atherosclerosis	0.000218	0.00199	CcSEcCtD
Etodolac—Malaise—Pravastatin—atherosclerosis	0.000218	0.00199	CcSEcCtD
Etodolac—Abdominal pain—Rosuvastatin—atherosclerosis	0.000217	0.00199	CcSEcCtD
Etodolac—Vertigo—Pravastatin—atherosclerosis	0.000217	0.00198	CcSEcCtD
Etodolac—Palpitations—Niacin—atherosclerosis	0.000217	0.00198	CcSEcCtD
Etodolac—Infection—Simvastatin—atherosclerosis	0.000217	0.00198	CcSEcCtD
Etodolac—Leukopenia—Pravastatin—atherosclerosis	0.000216	0.00198	CcSEcCtD
Etodolac—Loss of consciousness—Niacin—atherosclerosis	0.000216	0.00197	CcSEcCtD
Etodolac—Thrombocytopenia—Simvastatin—atherosclerosis	0.000213	0.00195	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000212	0.00194	CcSEcCtD
Etodolac—Insomnia—Lovastatin—atherosclerosis	0.000211	0.00193	CcSEcCtD
Etodolac—Paraesthesia—Lovastatin—atherosclerosis	0.000209	0.00191	CcSEcCtD
Etodolac—Myalgia—Niacin—atherosclerosis	0.000209	0.00191	CcSEcCtD
Etodolac—Arthralgia—Niacin—atherosclerosis	0.000209	0.00191	CcSEcCtD
Etodolac—Hypertension—Pravastatin—atherosclerosis	0.000208	0.00191	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000208	0.0019	CcSEcCtD
Etodolac—Anorexia—Simvastatin—atherosclerosis	0.000208	0.0019	CcSEcCtD
Etodolac—Dyspnoea—Lovastatin—atherosclerosis	0.000208	0.0019	CcSEcCtD
Etodolac—Insomnia—Ezetimibe—atherosclerosis	0.000207	0.00189	CcSEcCtD
Etodolac—Myalgia—Pravastatin—atherosclerosis	0.000206	0.00188	CcSEcCtD
Etodolac—Arthralgia—Pravastatin—atherosclerosis	0.000206	0.00188	CcSEcCtD
Etodolac—Paraesthesia—Ezetimibe—atherosclerosis	0.000205	0.00188	CcSEcCtD
Etodolac—Dyspepsia—Lovastatin—atherosclerosis	0.000205	0.00188	CcSEcCtD
Etodolac—Anxiety—Pravastatin—atherosclerosis	0.000205	0.00187	CcSEcCtD
Etodolac—Dry mouth—Niacin—atherosclerosis	0.000204	0.00187	CcSEcCtD
Etodolac—Dyspnoea—Ezetimibe—atherosclerosis	0.000204	0.00186	CcSEcCtD
Etodolac—Discomfort—Pravastatin—atherosclerosis	0.000203	0.00186	CcSEcCtD
Etodolac—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000203	0.00185	CcSEcCtD
Etodolac—Decreased appetite—Lovastatin—atherosclerosis	0.000203	0.00185	CcSEcCtD
Etodolac—Dyspepsia—Ezetimibe—atherosclerosis	0.000201	0.00184	CcSEcCtD
Etodolac—Fatigue—Lovastatin—atherosclerosis	0.000201	0.00184	CcSEcCtD
Etodolac—Anaphylactic shock—Niacin—atherosclerosis	0.0002	0.00183	CcSEcCtD
Etodolac—Oedema—Niacin—atherosclerosis	0.0002	0.00183	CcSEcCtD
Etodolac—Pain—Lovastatin—atherosclerosis	0.000199	0.00182	CcSEcCtD
Etodolac—Constipation—Lovastatin—atherosclerosis	0.000199	0.00182	CcSEcCtD
Etodolac—Confusional state—Pravastatin—atherosclerosis	0.000199	0.00182	CcSEcCtD
Etodolac—Decreased appetite—Ezetimibe—atherosclerosis	0.000199	0.00182	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000199	0.00182	CcSEcCtD
Etodolac—PTGS1—connective tissue—atherosclerosis	0.000198	0.0219	CbGeAlD
Etodolac—Asthenia—Rosuvastatin—atherosclerosis	0.000197	0.0018	CcSEcCtD
Etodolac—Insomnia—Simvastatin—atherosclerosis	0.000197	0.0018	CcSEcCtD
Etodolac—Anaphylactic shock—Pravastatin—atherosclerosis	0.000197	0.0018	CcSEcCtD
Etodolac—Oedema—Pravastatin—atherosclerosis	0.000197	0.0018	CcSEcCtD
Etodolac—Fatigue—Ezetimibe—atherosclerosis	0.000197	0.0018	CcSEcCtD
Etodolac—Shock—Niacin—atherosclerosis	0.000197	0.0018	CcSEcCtD
Etodolac—Infection—Pravastatin—atherosclerosis	0.000196	0.00179	CcSEcCtD
Etodolac—Paraesthesia—Simvastatin—atherosclerosis	0.000196	0.00179	CcSEcCtD
Etodolac—Pain—Ezetimibe—atherosclerosis	0.000195	0.00179	CcSEcCtD
Etodolac—Constipation—Ezetimibe—atherosclerosis	0.000195	0.00179	CcSEcCtD
Etodolac—Tachycardia—Niacin—atherosclerosis	0.000195	0.00179	CcSEcCtD
Etodolac—Pruritus—Rosuvastatin—atherosclerosis	0.000195	0.00178	CcSEcCtD
Etodolac—Dyspnoea—Simvastatin—atherosclerosis	0.000194	0.00178	CcSEcCtD
Etodolac—Hyperhidrosis—Niacin—atherosclerosis	0.000194	0.00177	CcSEcCtD
Etodolac—Thrombocytopenia—Pravastatin—atherosclerosis	0.000193	0.00176	CcSEcCtD
Etodolac—Feeling abnormal—Lovastatin—atherosclerosis	0.000192	0.00176	CcSEcCtD
Etodolac—Dyspepsia—Simvastatin—atherosclerosis	0.000192	0.00176	CcSEcCtD
Etodolac—Anorexia—Niacin—atherosclerosis	0.000191	0.00175	CcSEcCtD
Etodolac—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000191	0.00174	CcSEcCtD
Etodolac—Hyperhidrosis—Pravastatin—atherosclerosis	0.000191	0.00174	CcSEcCtD
Etodolac—Decreased appetite—Simvastatin—atherosclerosis	0.000189	0.00173	CcSEcCtD
Etodolac—PTGS2—connective tissue—atherosclerosis	0.000189	0.0209	CbGeAlD
Etodolac—CYP2C9—cardiovascular system—atherosclerosis	0.000189	0.0209	CbGeAlD
Etodolac—Feeling abnormal—Ezetimibe—atherosclerosis	0.000188	0.00172	CcSEcCtD
Etodolac—Diarrhoea—Rosuvastatin—atherosclerosis	0.000188	0.00172	CcSEcCtD
Etodolac—Fatigue—Simvastatin—atherosclerosis	0.000188	0.00172	CcSEcCtD
Etodolac—Anorexia—Pravastatin—atherosclerosis	0.000188	0.00172	CcSEcCtD
Etodolac—Hypotension—Niacin—atherosclerosis	0.000187	0.00171	CcSEcCtD
Etodolac—ALB—liver—atherosclerosis	0.000187	0.0207	CbGeAlD
Etodolac—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000187	0.00171	CcSEcCtD
Etodolac—Constipation—Simvastatin—atherosclerosis	0.000186	0.00171	CcSEcCtD
Etodolac—Pain—Simvastatin—atherosclerosis	0.000186	0.00171	CcSEcCtD
Etodolac—Urticaria—Lovastatin—atherosclerosis	0.000185	0.00169	CcSEcCtD
Etodolac—Abdominal pain—Lovastatin—atherosclerosis	0.000184	0.00169	CcSEcCtD
Etodolac—Body temperature increased—Lovastatin—atherosclerosis	0.000184	0.00169	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000182	0.00167	CcSEcCtD
Etodolac—Dizziness—Rosuvastatin—atherosclerosis	0.000182	0.00166	CcSEcCtD
Etodolac—Urticaria—Ezetimibe—atherosclerosis	0.000182	0.00166	CcSEcCtD
Etodolac—Insomnia—Niacin—atherosclerosis	0.000181	0.00166	CcSEcCtD
Etodolac—Body temperature increased—Ezetimibe—atherosclerosis	0.000181	0.00165	CcSEcCtD
Etodolac—Abdominal pain—Ezetimibe—atherosclerosis	0.000181	0.00165	CcSEcCtD
Etodolac—Paraesthesia—Niacin—atherosclerosis	0.00018	0.00164	CcSEcCtD
Etodolac—Feeling abnormal—Simvastatin—atherosclerosis	0.00018	0.00164	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00018	0.00164	CcSEcCtD
Etodolac—Dyspnoea—Niacin—atherosclerosis	0.000178	0.00163	CcSEcCtD
Etodolac—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000178	0.00163	CcSEcCtD
Etodolac—Insomnia—Pravastatin—atherosclerosis	0.000178	0.00163	CcSEcCtD
Etodolac—Somnolence—Niacin—atherosclerosis	0.000178	0.00163	CcSEcCtD
Etodolac—Paraesthesia—Pravastatin—atherosclerosis	0.000177	0.00162	CcSEcCtD
Etodolac—Dyspepsia—Niacin—atherosclerosis	0.000176	0.00161	CcSEcCtD
Etodolac—Dyspnoea—Pravastatin—atherosclerosis	0.000176	0.00161	CcSEcCtD
Etodolac—Decreased appetite—Niacin—atherosclerosis	0.000174	0.00159	CcSEcCtD
Etodolac—Dyspepsia—Pravastatin—atherosclerosis	0.000173	0.00159	CcSEcCtD
Etodolac—Rash—Rosuvastatin—atherosclerosis	0.000173	0.00159	CcSEcCtD
Etodolac—Dermatitis—Rosuvastatin—atherosclerosis	0.000173	0.00158	CcSEcCtD
Etodolac—Urticaria—Simvastatin—atherosclerosis	0.000173	0.00158	CcSEcCtD
Etodolac—PTGS1—cardiovascular system—atherosclerosis	0.000172	0.019	CbGeAlD
Etodolac—Body temperature increased—Simvastatin—atherosclerosis	0.000172	0.00158	CcSEcCtD
Etodolac—Abdominal pain—Simvastatin—atherosclerosis	0.000172	0.00158	CcSEcCtD
Etodolac—Headache—Rosuvastatin—atherosclerosis	0.000172	0.00158	CcSEcCtD
Etodolac—Hypersensitivity—Lovastatin—atherosclerosis	0.000172	0.00157	CcSEcCtD
Etodolac—Decreased appetite—Pravastatin—atherosclerosis	0.000171	0.00157	CcSEcCtD
Etodolac—Pain—Niacin—atherosclerosis	0.000171	0.00157	CcSEcCtD
Etodolac—Fatigue—Pravastatin—atherosclerosis	0.00017	0.00155	CcSEcCtD
Etodolac—Pain—Pravastatin—atherosclerosis	0.000169	0.00154	CcSEcCtD
Etodolac—Constipation—Pravastatin—atherosclerosis	0.000169	0.00154	CcSEcCtD
Etodolac—Hypersensitivity—Ezetimibe—atherosclerosis	0.000168	0.00154	CcSEcCtD
Etodolac—Asthenia—Lovastatin—atherosclerosis	0.000167	0.00153	CcSEcCtD
Etodolac—Pruritus—Lovastatin—atherosclerosis	0.000165	0.00151	CcSEcCtD
Etodolac—PTGS2—cardiovascular system—atherosclerosis	0.000165	0.0182	CbGeAlD
Etodolac—Asthenia—Ezetimibe—atherosclerosis	0.000164	0.0015	CcSEcCtD
Etodolac—Gastrointestinal pain—Niacin—atherosclerosis	0.000164	0.0015	CcSEcCtD
Etodolac—Nausea—Rosuvastatin—atherosclerosis	0.000163	0.00149	CcSEcCtD
Etodolac—Feeling abnormal—Pravastatin—atherosclerosis	0.000162	0.00149	CcSEcCtD
Etodolac—Pruritus—Ezetimibe—atherosclerosis	0.000162	0.00148	CcSEcCtD
Etodolac—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000161	0.00147	CcSEcCtD
Etodolac—Hypersensitivity—Simvastatin—atherosclerosis	0.000161	0.00147	CcSEcCtD
Etodolac—Diarrhoea—Lovastatin—atherosclerosis	0.000159	0.00146	CcSEcCtD
Etodolac—Urticaria—Niacin—atherosclerosis	0.000159	0.00145	CcSEcCtD
Etodolac—Body temperature increased—Niacin—atherosclerosis	0.000158	0.00145	CcSEcCtD
Etodolac—Abdominal pain—Niacin—atherosclerosis	0.000158	0.00145	CcSEcCtD
Etodolac—Urticaria—Pravastatin—atherosclerosis	0.000157	0.00143	CcSEcCtD
Etodolac—Asthenia—Simvastatin—atherosclerosis	0.000156	0.00143	CcSEcCtD
Etodolac—Diarrhoea—Ezetimibe—atherosclerosis	0.000156	0.00143	CcSEcCtD
Etodolac—Body temperature increased—Pravastatin—atherosclerosis	0.000156	0.00143	CcSEcCtD
Etodolac—Abdominal pain—Pravastatin—atherosclerosis	0.000156	0.00143	CcSEcCtD
Etodolac—Pruritus—Simvastatin—atherosclerosis	0.000154	0.00141	CcSEcCtD
Etodolac—Dizziness—Lovastatin—atherosclerosis	0.000154	0.00141	CcSEcCtD
Etodolac—PTGS1—adipose tissue—atherosclerosis	0.000152	0.0168	CbGeAlD
Etodolac—Dizziness—Ezetimibe—atherosclerosis	0.000151	0.00138	CcSEcCtD
Etodolac—Diarrhoea—Simvastatin—atherosclerosis	0.000149	0.00136	CcSEcCtD
Etodolac—Vomiting—Lovastatin—atherosclerosis	0.000148	0.00136	CcSEcCtD
Etodolac—Hypersensitivity—Niacin—atherosclerosis	0.000147	0.00135	CcSEcCtD
Etodolac—Rash—Lovastatin—atherosclerosis	0.000147	0.00134	CcSEcCtD
Etodolac—Dermatitis—Lovastatin—atherosclerosis	0.000147	0.00134	CcSEcCtD
Etodolac—Headache—Lovastatin—atherosclerosis	0.000146	0.00134	CcSEcCtD
Etodolac—Vomiting—Ezetimibe—atherosclerosis	0.000145	0.00133	CcSEcCtD
Etodolac—PTGS2—adipose tissue—atherosclerosis	0.000145	0.016	CbGeAlD
Etodolac—Hypersensitivity—Pravastatin—atherosclerosis	0.000145	0.00133	CcSEcCtD
Etodolac—Dizziness—Simvastatin—atherosclerosis	0.000144	0.00132	CcSEcCtD
Etodolac—Rash—Ezetimibe—atherosclerosis	0.000144	0.00132	CcSEcCtD
Etodolac—Dermatitis—Ezetimibe—atherosclerosis	0.000144	0.00132	CcSEcCtD
Etodolac—Asthenia—Niacin—atherosclerosis	0.000144	0.00131	CcSEcCtD
Etodolac—Headache—Ezetimibe—atherosclerosis	0.000143	0.00131	CcSEcCtD
Etodolac—Pruritus—Niacin—atherosclerosis	0.000142	0.0013	CcSEcCtD
Etodolac—Asthenia—Pravastatin—atherosclerosis	0.000141	0.00129	CcSEcCtD
Etodolac—Pruritus—Pravastatin—atherosclerosis	0.000139	0.00128	CcSEcCtD
Etodolac—Vomiting—Simvastatin—atherosclerosis	0.000139	0.00127	CcSEcCtD
Etodolac—Nausea—Lovastatin—atherosclerosis	0.000138	0.00127	CcSEcCtD
Etodolac—Rash—Simvastatin—atherosclerosis	0.000137	0.00126	CcSEcCtD
Etodolac—Dermatitis—Simvastatin—atherosclerosis	0.000137	0.00126	CcSEcCtD
Etodolac—Diarrhoea—Niacin—atherosclerosis	0.000137	0.00125	CcSEcCtD
Etodolac—Headache—Simvastatin—atherosclerosis	0.000137	0.00125	CcSEcCtD
Etodolac—Nausea—Ezetimibe—atherosclerosis	0.000136	0.00124	CcSEcCtD
Etodolac—Diarrhoea—Pravastatin—atherosclerosis	0.000135	0.00123	CcSEcCtD
Etodolac—Dizziness—Niacin—atherosclerosis	0.000132	0.00121	CcSEcCtD
Etodolac—Dizziness—Pravastatin—atherosclerosis	0.00013	0.00119	CcSEcCtD
Etodolac—Nausea—Simvastatin—atherosclerosis	0.000129	0.00118	CcSEcCtD
Etodolac—Vomiting—Niacin—atherosclerosis	0.000127	0.00116	CcSEcCtD
Etodolac—Rash—Niacin—atherosclerosis	0.000126	0.00115	CcSEcCtD
Etodolac—Dermatitis—Niacin—atherosclerosis	0.000126	0.00115	CcSEcCtD
Etodolac—Headache—Niacin—atherosclerosis	0.000125	0.00115	CcSEcCtD
Etodolac—Vomiting—Pravastatin—atherosclerosis	0.000125	0.00115	CcSEcCtD
Etodolac—Rash—Pravastatin—atherosclerosis	0.000124	0.00114	CcSEcCtD
Etodolac—Dermatitis—Pravastatin—atherosclerosis	0.000124	0.00114	CcSEcCtD
Etodolac—Headache—Pravastatin—atherosclerosis	0.000123	0.00113	CcSEcCtD
Etodolac—Nausea—Niacin—atherosclerosis	0.000119	0.00109	CcSEcCtD
Etodolac—Nausea—Pravastatin—atherosclerosis	0.000117	0.00107	CcSEcCtD
Etodolac—CYP2C9—liver—atherosclerosis	0.000117	0.0129	CbGeAlD
Etodolac—PTGS2—liver—atherosclerosis	0.000102	0.0113	CbGeAlD
Etodolac—ALB—Metabolism—APOA2—atherosclerosis	8.52e-06	8.55e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PLA2G2A—atherosclerosis	8.52e-06	8.55e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALOX15—atherosclerosis	8.52e-06	8.55e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALOX5AP—atherosclerosis	8.52e-06	8.55e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PDGFB—atherosclerosis	8.51e-06	8.55e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GPX1—atherosclerosis	8.42e-06	8.46e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—atherosclerosis	8.42e-06	8.45e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MMP1—atherosclerosis	8.42e-06	8.45e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ABCG5—atherosclerosis	8.41e-06	8.45e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	8.4e-06	8.44e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—MTHFR—atherosclerosis	8.34e-06	8.37e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CYBA—atherosclerosis	8.27e-06	8.31e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.27e-06	8.3e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—FABP4—atherosclerosis	8.25e-06	8.28e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LCAT—atherosclerosis	8.25e-06	8.28e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CG—atherosclerosis	8.24e-06	8.27e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—HMOX1—atherosclerosis	8.23e-06	8.26e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CD36—atherosclerosis	8.2e-06	8.24e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PPARA—atherosclerosis	8.18e-06	8.21e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—LPA—atherosclerosis	8.12e-06	8.16e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PPARG—atherosclerosis	8.11e-06	8.14e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PARP1—atherosclerosis	8.1e-06	8.13e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOA4—atherosclerosis	8.1e-06	8.13e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—CAV1—atherosclerosis	8.07e-06	8.1e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	8.07e-06	8.1e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—APOA1—atherosclerosis	8.05e-06	8.08e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NAMPT—atherosclerosis	8.03e-06	8.06e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.98e-06	8.01e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—LIPC—atherosclerosis	7.98e-06	8.01e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP7A1—atherosclerosis	7.96e-06	7.99e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PPARG—atherosclerosis	7.95e-06	7.98e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOC3—atherosclerosis	7.93e-06	7.96e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AGT—atherosclerosis	7.92e-06	7.95e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.91e-06	7.94e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—LDLR—atherosclerosis	7.88e-06	7.91e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APOB—atherosclerosis	7.88e-06	7.91e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—BGN—atherosclerosis	7.87e-06	7.9e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	7.83e-06	7.86e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ABCA1—atherosclerosis	7.82e-06	7.85e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	7.81e-06	7.84e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—INS—atherosclerosis	7.8e-06	7.83e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOA5—atherosclerosis	7.79e-06	7.82e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—MTHFR—atherosclerosis	7.77e-06	7.81e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—APOE—atherosclerosis	7.76e-06	7.79e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CETP—atherosclerosis	7.7e-06	7.73e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CAV1—atherosclerosis	7.69e-06	7.72e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—F2—atherosclerosis	7.68e-06	7.71e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—APOA1—atherosclerosis	7.67e-06	7.7e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTM1—atherosclerosis	7.66e-06	7.7e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PPARA—atherosclerosis	7.63e-06	7.66e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS2—atherosclerosis	7.59e-06	7.62e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.58e-06	7.61e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	7.57e-06	7.6e-05	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	7.56e-06	7.59e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—LPL—atherosclerosis	7.52e-06	7.55e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PLA2G1B—atherosclerosis	7.5e-06	7.53e-05	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.43e-06	7.46e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.41e-06	7.44e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AGT—atherosclerosis	7.39e-06	7.42e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SCARB1—atherosclerosis	7.37e-06	7.4e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP27A1—atherosclerosis	7.35e-06	7.38e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CG—atherosclerosis	7.35e-06	7.38e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.34e-06	7.38e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GPX1—atherosclerosis	7.34e-06	7.37e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.33e-06	7.36e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—SERPINE1—atherosclerosis	7.3e-06	7.33e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ALOX5—atherosclerosis	7.24e-06	7.27e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	7.24e-06	7.27e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—APOE—atherosclerosis	7.24e-06	7.27e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.18e-06	7.21e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CAV1—atherosclerosis	7.17e-06	7.2e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—APOA1—atherosclerosis	7.16e-06	7.19e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CD36—atherosclerosis	7.15e-06	7.18e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—ALB—atherosclerosis	7.15e-06	7.18e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	7.06e-06	7.09e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CG—atherosclerosis	7e-06	7.03e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALOX15—atherosclerosis	6.97e-06	7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	6.97e-06	7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	6.97e-06	7e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOA2—atherosclerosis	6.97e-06	7e-05	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.97e-06	7e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HMGCR—atherosclerosis	6.96e-06	6.99e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ABCG5—atherosclerosis	6.89e-06	6.91e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.88e-06	6.91e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—NOS3—atherosclerosis	6.84e-06	6.87e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—IL6—atherosclerosis	6.79e-06	6.82e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—MTHFR—atherosclerosis	6.77e-06	6.8e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PPARG—atherosclerosis	6.76e-06	6.79e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IGF1—atherosclerosis	6.73e-06	6.76e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—HMOX1—atherosclerosis	6.7e-06	6.73e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.69e-06	6.72e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LPA—atherosclerosis	6.65e-06	6.68e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PPARA—atherosclerosis	6.64e-06	6.67e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—INS—atherosclerosis	6.63e-06	6.66e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CG—atherosclerosis	6.53e-06	6.56e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NAMPT—atherosclerosis	6.49e-06	6.52e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.46e-06	6.48e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—LIPC—atherosclerosis	6.45e-06	6.48e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—BGN—atherosclerosis	6.44e-06	6.47e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AGT—atherosclerosis	6.44e-06	6.46e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APOB—atherosclerosis	6.42e-06	6.45e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOC3—atherosclerosis	6.41e-06	6.44e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.39e-06	6.42e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SERPINE1—atherosclerosis	6.39e-06	6.42e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOA5—atherosclerosis	6.38e-06	6.4e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—LDLR—atherosclerosis	6.38e-06	6.4e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APOE—atherosclerosis	6.31e-06	6.33e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PPARG—atherosclerosis	6.3e-06	6.33e-05	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT1—atherosclerosis	6.27e-06	6.29e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—atherosclerosis	6.25e-06	6.28e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTM1—atherosclerosis	6.25e-06	6.27e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CAV1—atherosclerosis	6.25e-06	6.27e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—APOA1—atherosclerosis	6.23e-06	6.26e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CETP—atherosclerosis	6.23e-06	6.25e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ABCA1—atherosclerosis	6.2e-06	6.23e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.19e-06	6.22e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—INS—atherosclerosis	6.18e-06	6.21e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	6.14e-06	6.16e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—LPL—atherosclerosis	6.13e-06	6.16e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—NOS3—atherosclerosis	6.1e-06	6.13e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APOB—atherosclerosis	6.09e-06	6.11e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—ALB—atherosclerosis	6.08e-06	6.1e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.07e-06	6.09e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.01e-06	6.04e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6e-06	6.02e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GPX1—atherosclerosis	5.98e-06	6.01e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—SCARB1—atherosclerosis	5.96e-06	5.99e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALOX5—atherosclerosis	5.93e-06	5.95e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CD36—atherosclerosis	5.83e-06	5.85e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—NOS3—atherosclerosis	5.81e-06	5.84e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—LPL—atherosclerosis	5.81e-06	5.84e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CG—atherosclerosis	5.69e-06	5.71e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—ALB—atherosclerosis	5.67e-06	5.69e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PRKCG—atherosclerosis	5.65e-06	5.68e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—HMGCR—atherosclerosis	5.63e-06	5.65e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—MTHFR—atherosclerosis	5.52e-06	5.54e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PPARG—atherosclerosis	5.49e-06	5.52e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.48e-06	5.5e-05	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	5.44e-06	5.46e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—NOS3—atherosclerosis	5.42e-06	5.45e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PPARA—atherosclerosis	5.42e-06	5.44e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—INS—atherosclerosis	5.39e-06	5.41e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—HMOX1—atherosclerosis	5.32e-06	5.34e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—atherosclerosis	5.32e-06	5.34e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NAMPT—atherosclerosis	5.32e-06	5.34e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.29e-06	5.31e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LIPC—atherosclerosis	5.28e-06	5.3e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOC3—atherosclerosis	5.25e-06	5.27e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AGT—atherosclerosis	5.25e-06	5.27e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MTHFR—atherosclerosis	5.23e-06	5.26e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LDLR—atherosclerosis	5.22e-06	5.24e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APOE—atherosclerosis	5.14e-06	5.16e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOB—atherosclerosis	5.1e-06	5.12e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CETP—atherosclerosis	5.1e-06	5.12e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PDGFB—atherosclerosis	5.09e-06	5.12e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CAV1—atherosclerosis	5.09e-06	5.11e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—APOA1—atherosclerosis	5.08e-06	5.1e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.08e-06	5.1e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—ABCA1—atherosclerosis	5.02e-06	5.04e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTM1—atherosclerosis	4.96e-06	4.98e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—atherosclerosis	4.96e-06	4.98e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—ALB—atherosclerosis	4.94e-06	4.96e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SCARB1—atherosclerosis	4.88e-06	4.9e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APOE—atherosclerosis	4.87e-06	4.89e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—LPL—atherosclerosis	4.87e-06	4.89e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—CAV1—atherosclerosis	4.83e-06	4.85e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—APOA1—atherosclerosis	4.82e-06	4.84e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MAPK3—atherosclerosis	4.75e-06	4.77e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.75e-06	4.77e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GPX1—atherosclerosis	4.75e-06	4.77e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—NOS3—atherosclerosis	4.72e-06	4.74e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CG—atherosclerosis	4.64e-06	4.66e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CD36—atherosclerosis	4.63e-06	4.64e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HMGCR—atherosclerosis	4.61e-06	4.63e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS2—atherosclerosis	4.54e-06	4.56e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PPARG—atherosclerosis	4.48e-06	4.5e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—atherosclerosis	4.39e-06	4.41e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—INS—atherosclerosis	4.39e-06	4.41e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—MTHFR—atherosclerosis	4.38e-06	4.4e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—atherosclerosis	4.32e-06	4.34e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—HMOX1—atherosclerosis	4.31e-06	4.32e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PPARA—atherosclerosis	4.3e-06	4.32e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AGT—atherosclerosis	4.16e-06	4.18e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—INS—atherosclerosis	4.16e-06	4.18e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.16e-06	4.17e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK3—atherosclerosis	4.16e-06	4.17e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOB—atherosclerosis	4.12e-06	4.14e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ABCA1—atherosclerosis	4.11e-06	4.13e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOE—atherosclerosis	4.08e-06	4.1e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CAV1—atherosclerosis	4.04e-06	4.06e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—APOA1—atherosclerosis	4.03e-06	4.05e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TGFB1—atherosclerosis	4.03e-06	4.05e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—ALB—atherosclerosis	4.03e-06	4.04e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTM1—atherosclerosis	4.01e-06	4.03e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—LPL—atherosclerosis	3.94e-06	3.95e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—NOS3—atherosclerosis	3.85e-06	3.87e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—GPX1—atherosclerosis	3.84e-06	3.86e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—SERPINE1—atherosclerosis	3.82e-06	3.84e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CD36—atherosclerosis	3.74e-06	3.76e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CG—atherosclerosis	3.68e-06	3.7e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOS3—atherosclerosis	3.65e-06	3.67e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PPARG—atherosclerosis	3.55e-06	3.57e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—MTHFR—atherosclerosis	3.55e-06	3.56e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.52e-06	3.54e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—atherosclerosis	3.52e-06	3.54e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—INS—atherosclerosis	3.49e-06	3.5e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPARA—atherosclerosis	3.48e-06	3.49e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOB—atherosclerosis	3.38e-06	3.39e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AGT—atherosclerosis	3.37e-06	3.38e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOE—atherosclerosis	3.3e-06	3.32e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.28e-06	3.3e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CAV1—atherosclerosis	3.27e-06	3.28e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—APOA1—atherosclerosis	3.26e-06	3.28e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—LPL—atherosclerosis	3.22e-06	3.24e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AKT1—atherosclerosis	3.21e-06	3.22e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—ALB—atherosclerosis	3.2e-06	3.21e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GPX1—atherosclerosis	3.15e-06	3.16e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKT1—atherosclerosis	3.14e-06	3.16e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CD36—atherosclerosis	3.06e-06	3.08e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NOS3—atherosclerosis	3.06e-06	3.07e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CG—atherosclerosis	2.98e-06	2.99e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.9e-06	2.91e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPARG—atherosclerosis	2.88e-06	2.89e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPARA—atherosclerosis	2.85e-06	2.86e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—INS—atherosclerosis	2.82e-06	2.83e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT1—atherosclerosis	2.8e-06	2.82e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AGT—atherosclerosis	2.76e-06	2.77e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOE—atherosclerosis	2.7e-06	2.71e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CAV1—atherosclerosis	2.68e-06	2.69e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKT1—atherosclerosis	2.67e-06	2.68e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—APOA1—atherosclerosis	2.67e-06	2.68e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—atherosclerosis	2.6e-06	2.61e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKT1—atherosclerosis	2.49e-06	2.5e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK3—atherosclerosis	2.49e-06	2.5e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NOS3—atherosclerosis	2.47e-06	2.48e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.44e-06	2.45e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—TGFB1—atherosclerosis	2.41e-06	2.42e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPARG—atherosclerosis	2.35e-06	2.36e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—INS—atherosclerosis	2.31e-06	2.32e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—atherosclerosis	2.26e-06	2.27e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKT1—atherosclerosis	2.17e-06	2.18e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ALB—atherosclerosis	2.12e-06	2.13e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NOS3—atherosclerosis	2.02e-06	2.03e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.85e-06	1.86e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—IL6—atherosclerosis	1.82e-06	1.83e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKT1—atherosclerosis	1.77e-06	1.78e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT1—atherosclerosis	1.68e-06	1.68e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKT1—atherosclerosis	1.41e-06	1.41e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKT1—atherosclerosis	1.14e-06	1.14e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKT1—atherosclerosis	9.31e-07	9.34e-06	CbGpPWpGaD
